Subscribe free

Cytoreductive Surgery & Peritoneum ·

Cytoreductive surgery with HIPEC improves survival in CRC patients.

A systematic review and meta-analysis encompassing 14 studies reveal that colorectal cancer patients with peritoneal metastases experience enhanced overall survival (OS) and relapse-free survival (RFS) following cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC). Compared to control regimens, the CRS + HIPEC approach markedly improves these outcomes, shedding light on effective therapeutic strategies for managing advanced disease stage in colorectal cancer.

Meta-Analysis by Peng W, Li J (…) Lu J et 3 al. in Ann Ital Chir

read the whole article in Ann Ital Chir

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Cytoreductive Surgery & Peritoneum.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Cytoreductive Surgery & Peritoneum

The latest stitches

Ann Surg Oncol28 Aug 2026

Prophylactic HIPEC Improves Survival in Advanced Colorectal Cancer

Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.

All papers in Cytoreductive Surgery & Peritoneum →